Treatment . | Social status . | SGR (% growth/day) . | CFf(100×g cm-3) . |
---|---|---|---|
Cortisol | Dominant | 0.25±0.12a (14) | 1.09±0.03 (14) |
Subordinate | -1.16±0.19b (14) | 0.99±0.03 (14) | |
Cortisol+RU486 | Dominant | -0.58±0.13b (10) | 1.04±0.03 (10) |
Subordinate | -1.01±0.13b (10) | 1.05±0.04 (10) |
Treatment . | Social status . | SGR (% growth/day) . | CFf(100×g cm-3) . |
---|---|---|---|
Cortisol | Dominant | 0.25±0.12a (14) | 1.09±0.03 (14) |
Subordinate | -1.16±0.19b (14) | 0.99±0.03 (14) | |
Cortisol+RU486 | Dominant | -0.58±0.13b (10) | 1.04±0.03 (10) |
Subordinate | -1.01±0.13b (10) | 1.05±0.04 (10) |
SGR, specific growth rate; CFf, final condition factor.
Values are means ± 1 s.e.m. (N). For SGR, groups that do not share a letter are significantly different from one another(two-way ANOVA with treatment group and social status as factors, P=0.036 for treatment group, P<0.001 for social status,and P=0.003 for interactions between these two factors); there were no significant effects of treatment group or social status on CFf(two-way ANOVA, P=0.937 for treatment group, P=0.141 for social status, and P=0.088 for interactions).